**Core Concept**
The BRAF proto-oncogene encodes a serine/threonine kinase that plays a crucial role in the regulation of cell growth and division. Activation of BRAF leads to the phosphorylation and activation of MEK, which subsequently activates ERK, promoting cell proliferation.

**Why the Correct Answer is Right**
BRAF is a key downstream effector of the RAS signaling pathway, and mutations in BRAF can lead to its constitutive activation, driving cancer cell growth. The most common BRAF mutation is the V600E mutation, which results in the substitution of glutamic acid for valine at position 600, leading to the activation of the BRAF kinase domain. This mutation is commonly found in melanoma and other cancers.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the main proto-oncogene associated with glioblastoma is EGFR, not BRAF.
**Option B:** This option is incorrect because while BRAF mutations can occur in colorectal cancer, the main proto-oncogene associated with this disease is KRAS.
**Option C:** This option is incorrect because the main proto-oncogene associated with lung cancer is EGFR, not BRAF.

**Clinical Pearl / High-Yield Fact**
The BRAF V600E mutation is a well-known driver mutation in melanoma, and targeted therapy with BRAF inhibitors such as vemurafenib has revolutionized the treatment of this disease.

**Correct Answer: C. Melanoma**